Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Muhammet Bekir Hacioglu"'
Autor:
Hilmi Kodaz, Muhammet Bekir Hacioglu, Cagnur Elpen Kodaz, Ahmet Cinkaya, Bulent Erdogan, Irfan Cicin
Publikováno v:
Journal of Oncological Sciences, Vol 2, Iss 1, Pp 25-26 (2016)
Background: Endometrial cancer is the most common gynecological cancer in developed countries. Autoimmune thrombocytopenia is a rare cause of thrombocytopenia in solid tumors and to the best of our knowledge, this is the first case reported associate
Externí odkaz:
https://doaj.org/article/2bf2e282c94f4d61837b88b6d40eed96
Autor:
Irfan Cicin, E. Özcan, Muhammet Bekir Hacioglu, Sernaz Uzunoglu, Bulent Erdogan, I. Gökmen, Ali Gökyer, Ahmet Kucukarda
Publikováno v:
Actas Urológicas Españolas. 46:301-309
Resumen Objetivo El objetivo del presente articulo fue identificar el valor pronostico del indice nutricional pronostico (INP) basal en pacientes con cancer de prostata resistente a la castracion metastasico (CPRCm) tratados con acetato de abirateron
Autor:
Muhammet Bekir Hacioglu, Bulent Erdogan, Murat Bardakcı, Efnan Algın, Burcu Gulbagcı, Ilhan Hacibekiroglu, Jamshid Hamdard, Omer Fatih Olmez, Hadi Akkus, Berna Oksuzoglu, Sema Sezgin Goksu, Shute Ailia Dae, Ahmet Taner Sumbul, Muzaffer Ugraklı, Mustafa Karaagac, Elif Sahin, Devrim Cabuk, Ozden Ozer, Tugba Yavuzsen, Rukiye Arıkan, Osman Köstek, Muhammed Mustafa Atcı, Abdullah Sakin, Adem Deligonul, Duygu Bayır, Murat Dincer, Oktay Unsal, Ozan Yazıcı, Esra Zeynelgil, Ahmet Gulmez, Hakan Harputluoglu, Cihan Erol, Mehmet Ali Nahit Sendur, Aydin Aytekin, Baran Akagunduz, Irem Oner, Ozlem Er, Bugra Oztosun, Mahmut Gumus, Fatih Selcuk Biricik, Musa Baris Aykan, Nuri Karadurmus, Ezgi Degerli, Nebi Serkan Demirci, Esma Turkmen, Teoman Şakalar, Saban Secmeler, Ozgur Tanrıverdi, Ali Alkan, Yasemin Kemal, Ibrahim Cil, Caglar Unal, Yakup Iriagaç, Ozkan Alan, Sevinc Balli, Yuksel Urun, Erkan Ozcan, Nazım Serdar Turhal, Irfan Cicin
Publikováno v:
Head & Neck.
Background: Most of the studies on salivary gland cancers are limited for various reasons such as being single-center, small number of patients, including only major or minor SGCs, or only including epidemiological data. Methods: A total of 37 medica
Autor:
Ahmet Kucukarda, Erkan Ozcan, İvo Gökmen, Sezin Sayın, Muhammet Bekir Hacioglu, Sernaz Uzunoglu, Bulent Erdogan, Irfan Cicin, Ali Gökyer
Publikováno v:
Supportive Care in Cancer. 30:2131-2139
Purpose: We aimed to identify the prognostic and predictive values of post-treatment prognostic nutritional index (PNI) and PNI dynamics in nasopharyngeal cancer patients (NPC) in this study.Methods: 107 non-metastatic NPC patients were included. PNI
Autor:
Osman Kostek, Ahmet Kucukarda, Erkan Ozcan, Irfan Cicin, Sernaz Uzunoglu, Ali Gökyer, Muhammet Bekir Hacioglu, Sezin Sayın, İvo Gökmen, Bulent Erdogan
Publikováno v:
Journal of Gastrointestinal Cancer. 53:31-40
Transverse colon cancer (TCC) is a rare condition that accounts for 10% of all colon cancers. TCC was accepted more likely right-sided colon cancers. We aimed to investigate whether TCC differs from other colon tumors by using clinical, pathological,
Autor:
Osman Kula, Ahmet Kucukarda, Muhammet Bekir Hacioglu, Bulent Erdogan, Osman Kostek, Sernaz Uzunoglu, Irfan Cicin, Nazmi Kurt, Ali Gökyer, Sedat Ustundag
Publikováno v:
International Journal of Clinical Oncology. 25:1757-1762
Contrast nephropathy risk has been increasing in cancer patients. Nephrotoxic side effects of anti-vascular endothelial growth factor/receptor (anti-VEGF/R) drugs used in oncologic treatment are also prominent. The purpose of this study was to identi
Autor:
Bulent, Erdogan, Osman, Kostek, Muhammet, Bekir Hacioglu, Ali, Gokyer, Ahmet, Kucukarda, Erkan, Ozcan, Ivo, Gokmen, Sernaz, Uzunoglu, Irfan, Cicin
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(5)
To demonstrate whether early changes in systemic inflammatory markers are related with pazopanib treatment response in soft tissue sarcoma and renal cell carcinoma.Forty-one patients with metastatic clear cell renal carcinoma (mRCC) (n=22) and advanc
Autor:
H Eslame, Ahmet Kucukarda, S Solak, Ali Gökyer, Erdem Yilmaz, Irfan Cicin, Nazım Can Demircan, Sernaz Uzunoglu, Muhammet Bekir Hacioglu, Nermin Tuncbilek, Osman Kostek, B S Sunal, Bulent Erdogan
Publikováno v:
Clinical and Translational Oncology. 21:1510-1517
We aimed to assess whether anti-EGFR combined chemotherapy regimens are related with loss of skeletal muscle mass and to compare cetuximab and panitumumab therapies in the aspect of skeletal muscle area change as well as to assess whether skeletal mu
Publikováno v:
İstanbul Medical Journal, Vol 20, Iss 2, Pp 82-87 (2019)
Introduction:The clinical benefit of regorafenib therapy in metastatic colorectal cancer (mCRC) patients, who were previously treated with 5-fluorouracil (5-FU), irinotecan, or oxaliplatine based regimens with or without a biologic agent such as vasc
Autor:
Mert Saynak, Necdet Sut, Osman Kostek, Ebru Tastekin, Funda Ustun, Irfan Cicin, Muhammet Bekir Hacioglu, Bulent Erdogan, Hilmi Kodaz, Gulay Durmus-Altun, Ulku Korkmaz
Publikováno v:
Polish Journal of Radiology
Purpose 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) combined with computed tomography (CT) scan is accepted as a standard tool in the staging of oesophageal cancer (OC). Histological subtype of tumour is known to be a major de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0266d88486deecfc10a54f0b289dc980
https://ruj.uj.edu.pl/xmlui/handle/item/165458
https://ruj.uj.edu.pl/xmlui/handle/item/165458